FDA Gives Then Rescinds Clearance For Aurobindo Plant
Shares Plunge As FDA Says Investigation Into Unit IV ‘Still Open’
Aurobindo Pharma shares have nosedived after the US Food and Drug Administration said an investigation into one of the Indian drugmaker’s plants was still open, days after issuing a notice giving the site the all-clear.
